List of contributors, |
|
vii | |
Acknowledgements, |
|
ix | |
Foreword, |
|
x | |
Preface, |
|
xiii | |
Part 1 General considerations |
|
|
1 Movement disorders: an overview, |
|
|
3 | (17) |
|
Martin Cloutier, Anthony E. Lang |
|
|
|
2 Rating scales for movement disorders, |
|
|
20 | (10) |
|
Ikwunga Wonodi, Elliot L. Hong, Matthew T. Avila, Gunvant K. Thaker |
|
|
|
3 Spontaneous movement disorders in psychiatric patients, |
|
|
30 | (25) |
|
Irene Richard, Christopher O'Brien, Roger Kurlan |
|
|
Part 2 Antipsychotics |
|
|
4 The pharmacology of typical and atypical antipsychotics, |
|
|
55 | (17) |
|
Gary Remington, Shitij Kapur |
|
|
|
5 Acute drug-induced dystonia, |
|
|
72 | (31) |
|
Michael F. Mazurek, Patricia I. Rosebush |
|
|
|
6 Drug-induced parkinsonism, |
|
|
103 | (37) |
|
Joseph H. Friedman, Martha E. Trieschmann, Hubert H. Fernandez |
|
|
|
7 Acute drug-induced akathisia, |
|
|
140 | (34) |
|
Lenard A. Adler, John Rotrosen, Burt Angrist |
|
|
|
8 Neuroleptic malignant syndrome, |
|
|
174 | (39) |
|
|
|
|
213 | (44) |
|
Thomas M. Hyde, Jose A. Apud, Whitney C. Fisher, Michael F. Egan |
|
|
|
10 Neuroleptic-induced tardive dyskinesia variants, |
|
|
257 | (28) |
|
Frank Skidmore, William J. Weiner, Robert Burke |
|
|
|
11 Movement disorders due to atypical antipsychotics, |
|
|
285 | (17) |
|
|
|
12 Commentary: is tardive dyskinesia disappearing?, |
|
|
302 | (11) |
|
|
Part 3 Dopaminomimetic drugs |
|
|
13 Dyskinesia induced by levodopa and dopamine agonists in patients with Parkinson's disease, |
|
|
313 | (38) |
|
John G. Nutt, Matthew A. Brodsky |
|
|
|
14 Movement disorders and dopaminomimetic stimulant drugs, |
|
|
351 | (22) |
|
Anthony E. Munson, Juan Sanchez-Ramos, William J. Weiner |
|
|
Part 4 Other drugs |
|
|
|
373 | (35) |
|
Maria L. Moro-de-Casillas, David E. Riley |
|
|
|
|
408 | (22) |
|
John C. Morgan, Madaline B. Harrison |
|
|
|
17 Miscellaneous drug-induced movement disorders, |
|
|
430 | (12) |
|
|
Index, |
|
442 | |